188 related articles for article (PubMed ID: 6436892)
1. Catecholamine metabolism during clonidine withdrawal.
Martin PR; Ebert MH; Gordon EK; Weingartner H; Kopin IJ
Psychopharmacology (Berl); 1984; 84(1):58-63. PubMed ID: 6436892
[TBL] [Abstract][Full Text] [Related]
2. Urinary catecholamine metabolites and effects of clonidine in patients with alcohol amnestic disorder.
Martin PR; Ebert MH; Gordon EK; Kopin IJ
Clin Pharmacol Ther; 1983 Jan; 33(1):19-27. PubMed ID: 6848295
[TBL] [Abstract][Full Text] [Related]
3. Catecholamine metabolism during heroin use.
Schildkraut JJ; Meyer RE; Orsulak PJ; Mirin SM; Roffman M; Platz PA; Grab E; Randall ME; McDougle M
Am J Psychiatry; 1977 May; 134(5):534-7. PubMed ID: 848581
[TBL] [Abstract][Full Text] [Related]
4. Excretion of catecholamine metabolites during methadone maintenance and withdrawal.
De Leon-Jones FA; Davis JM; Inwang EE; Dekirmenjian H
Arch Gen Psychiatry; 1983 Aug; 40(8):841-7. PubMed ID: 6870481
[TBL] [Abstract][Full Text] [Related]
5. Regimen for the control of blood pressure and symptoms during clonidine withdrawal.
Campbell BC; Reid JL
Int J Clin Pharmacol Res; 1985; 5(4):215-22. PubMed ID: 4055164
[TBL] [Abstract][Full Text] [Related]
6. Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Behavioral, cardiovascular, and neurochemical effects.
Leckman JF; Ort S; Caruso KA; Anderson GM; Riddle MA; Cohen DJ
Arch Gen Psychiatry; 1986 Dec; 43(12):1168-76. PubMed ID: 3465278
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of catecholamines and their metabolites in relation to circulating catecholamines. Six-hour infusion of epinephrine and norepinephrine in healthy volunteers.
Moleman P; Tulen JH; Blankestijn PJ; Man in 't Veld AJ; Boomsma F
Arch Gen Psychiatry; 1992 Jul; 49(7):568-72. PubMed ID: 1627048
[TBL] [Abstract][Full Text] [Related]
8. Day-to-day intraindividual reliability and interindividual differences in monoamines excretion.
Curtin F; Walker JP; Schulz P
J Affect Disord; 1996 Jun; 38(2-3):173-8. PubMed ID: 8791186
[TBL] [Abstract][Full Text] [Related]
9. The effect of methylphenidate on urinary catecholamine excretion in hyperactivity: a partial replication.
Zametkin AJ; Hamburger SD
Biol Psychiatry; 1988 Feb; 23(4):350-6. PubMed ID: 3342265
[TBL] [Abstract][Full Text] [Related]
10. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
Schildkraut JJ; Orsulak PJ; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA; LaBrie RA
Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878
[TBL] [Abstract][Full Text] [Related]
11. Catecholamine measures for diagnosis and treatment of patients with depressive disorders.
Schatzberg AF; Orsulak PJ; Rosenbaum AH; Kruger ER; Schildkraut JJ; Cole JO
J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):35-9. PubMed ID: 7440524
[TBL] [Abstract][Full Text] [Related]
12. Relative activity of metabolic pathways for norepinephrine in endogenous depression.
Roy A; Linnoila M; Karoum F; Pickar D
Acta Psychiatr Scand; 1986 Jun; 73(6):624-8. PubMed ID: 3751666
[TBL] [Abstract][Full Text] [Related]
13. Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline.
Reid JL; Wing LM; Dargie HJ; Hamilton CA; Davies DS; Dollery CT
Lancet; 1977 Jun; 1(8023):1171-4. PubMed ID: 68274
[TBL] [Abstract][Full Text] [Related]
14. Elevation of urinary catecholamines and their metabolites following tyrosine administration in humans.
Alonso R; Gibson CJ; Wurtman RJ; Agharanya JC; Prieto L
Biol Psychiatry; 1982 Jul; 17(7):781-90. PubMed ID: 7115832
[TBL] [Abstract][Full Text] [Related]
15. Effects of clonidine on central and peripheral catecholamine metabolism.
Martin PR; Ebert MH; Gordon EK; Linnoila M; Kopin IJ
Clin Pharmacol Ther; 1984 Mar; 35(3):322-7. PubMed ID: 6199153
[TBL] [Abstract][Full Text] [Related]
16. Methylated catecholamine metabolites for diagnosis of neuroblastoma.
Candito M; Thyss A; Albertini M; Deville A; Politano S; Mariani R; Chambon P
Med Pediatr Oncol; 1992; 20(3):215-20. PubMed ID: 1574031
[TBL] [Abstract][Full Text] [Related]
17. Increased catecholamine excretion after labetalol therapy: a spurious effect of drug metabolites.
Miano L; Kolloch R; De Quattro V
Clin Chim Acta; 1979 Jul; 95(2):211-7. PubMed ID: 527220
[TBL] [Abstract][Full Text] [Related]
18. Catecholamine metabolism and disposition in healthy and depressed subjects.
Maas JW; Koslow SH; Davis J; Katz M; Frazer A; Bowden CL; Berman N; Gibbons R; Stokes P; Landis DH
Arch Gen Psychiatry; 1987 Apr; 44(4):337-44. PubMed ID: 3566456
[TBL] [Abstract][Full Text] [Related]
19. Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites.
Schildkraut JJ; Orsulak PJ; LaBrie RA; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA
Arch Gen Psychiatry; 1978 Dec; 35(12):1436-9. PubMed ID: 727879
[TBL] [Abstract][Full Text] [Related]
20. Indices of noradrenergic output in depression.
Siever LJ; Uhde TW; Jimerson DC; Lake CR; Kopin IJ; Murphy DL
Psychiatry Res; 1986 Sep; 19(1):59-73. PubMed ID: 3786600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
